VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

SABCS 2021 | PROCURE: Genomic signatures and adjuvant chemotherapy for breast cancer in Europe

Giuseppe Curigliano, MD, PhD, University of Milan and European Institute of Oncology, Milan, Italy, discusses the PROCURE project, a survey across European investigators about use of genomic signatures to make decisions about adjuvant chemotherapy use in early breast cancer. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

Disclosures

Consultation fees from Pfizer, Roche, Astra Zeneca, BMS, Daichii Sankyo, Seagen, Gilead, Novartis, Lilly; Ellipsis, Merck

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter